Skip to main content
Anita Kumar, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

AnitaKumarMD

Oncology New York, NY

Hematologic Oncology

Associate Attending, Lymphoma Service, Memorial Sloan Kettering Cancer Center

Overview of Dr. Kumar

Dr. Anita Kumar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Overlook Medical Center, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from McGaw Medical Center of Northwestern University and has been in practice 9 years. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 44 doctors at Overlook Medical Center who specialize in Oncology. She has more than 30 publications and over 300 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2024
  • PA State Medical License
    PA State Medical License 2020 - 2024
  • MA State Medical License
    MA State Medical License 2010 - 2011

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
    Anita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
    Anita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience
    Anita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Azar Faulted Workers’ ‘Home and Social’ Situations for Meatpacking Outbreaks
    Azar Faulted Workers’ ‘Home and Social’ Situations for Meatpacking OutbreaksMay 7th, 2020

Hospital Affiliations